LZM008 , a proposed tocilizumab biosimilar: Pharmacokinetics, safety, and immunogenicity profiles compared wit https://t.co/kXYdBJEHy0 https://t.co/e5SG8ddmVk
74 followers
132 followers
BAT1806 China'sBio-Thera; seller: MA's Biogen CT-P47 Korea'sCelltrion DRL_TC India'sDr. Reddy's LZM008 China'sLivzon MSB11456 Germany'sFresenius Temziva Iran'sAryoGen & Singapore'sSRS; seller: PH's Biocare Tocira India's Hetero Tolosa Bangladesh's Inc
163 followers
RT @FrontPharmacol: New Research: LZM008, a proposed tocilizumab biosimilar: Pharmacokinetics, safety, and immunogenicity profiles compared…
5,774 followers
New Research: LZM008, a proposed tocilizumab biosimilar: Pharmacokinetics, safety, and immunogenicity profiles compared with ACTEMRA® in Chinese healthy male subjects https://t.co/0Aa3sBDZjg #pharmacology